Lobomycosis

• Published in: Clinics in dermatology Vol. 30; no. 4; pp. 420 - 424
• Main Authors: Talhari, Sinésio, Talhari, Carolina
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.07.2012
• Subjects: Antifungal Agents - therapeutic use; Clofazimine - therapeutic use; Dermatology; Diagnosis, Differential; Female; Humans; Itraconazole - therapeutic use; Lacazia - isolation & purification; Leprostatic Agents - therapeutic use; Lobomycosis - drug therapy; Lobomycosis - pathology; Male; Prognosis; Sex Factors; South America; Treatment Outcome; South America

Lobomycosis is a rare chronic fungal infection of the subcutaneous tissue found in South America, mainly in Brazil. It is caused by Lacazia loboi. Its clinical manifestations are dermal nodules, either lenticular or in plaques, and keloidlike lesions that can resemble nodular leprosy or leishmaniasi...